Reversing Underage Use Trends
Tobacco products are for adults. And we recognize that underage use of tobacco products threatens the opportunity to reduce harm among adult smokers.
FDA has called underage use of e-vapor an epidemic and says more must be done. We agree. That’s one reason we support raising the minimum age of purchase for all tobacco products to 21. Today the number one way kids get tobacco products is through social access – the purchase of such products by consumers of legal age for use by minors. Making the age of purchase 21 should significantly reduce that access.
Addressing the alarming rise in youth use of e-vapor is important if we want policy makers to more fully support the idea of giving adults greater access to and information about less harmful products. To learn more about our efforts to prevent kids from using any tobacco products, click here.
Seeking Authorization to Communicate Reduced Harm Information
We can only compete in the marketplace with products authorized by the FDA. And we can only communicate reduced harm information if the FDA permits.
That's why we are seeking authorization from FDA to put truthful, accurate information about reduced-risk products in the hands of consumers so that they can make a choice that's right for them.
To date, we have:
- Submitted a Modified Risk Tobacco Product application (MRTPA) for Copenhagen Snuff;
- Supported Philip Morris International (PMI) on its MRTPA application for IQOS. Philip Morris USA has an exclusive agreement with PMI to commercialize IQOS in the United States;
We believe it is critically important that FDA take steps to foster the innovation of potentially reduced risk products. For tobacco harm reduction to be successful, a marketplace of FDA-authorized reduced-risk products must be in place, with more information about the relative risks of those products being communicated to adult smokers. The regulatory system should respect the rights of adults to make decisions based on accurate information. To make this a reality, FDA needs to establish clear foundational rules for bringing these new innovative products to market.